Global Paclitaxel Market by Manufacturers, Regions, Type and Application, Forecast to 2021
- Id : RNR-44172
- Category : Pharma Healthcare
- Publish Date : Dec-16
- Pages : 117
- Publisher : GlobalInfo Research
Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol". Paclitaxel is a white crystalline powder, odorless and tasteless. It is insoluble in water and soluble in chloroform, acetone and other organic solvents. Scope of the Report: This report focuses on the Paclitaxel in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Phyton ScinoPharm Novasep Samyang Polymed TAPI(Teva) Fresenius-kabi Southpharma Haiyao Huiang biopharma Yunnan Hande Hainan Yew Pharm Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America, Middle East and Africa Market Segment by Type, covers Natural Paclitaxel Semi-synthetic Paclitaxel Market Segment by Applications, can be divided into Ovarian Cancer Cervical Cancer Breast Cancer Other There are 13 Chapters to deeply display the global Paclitaxel market. Chapter 1, to describe Paclitaxel Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Paclitaxel, with sales, revenue, and price of Paclitaxel, in 2015 and 2016; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016; Chapter 4, to show the global market by regions, with sales, revenue and market share of Paclitaxel, for each region, from 2011 to 2016; Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions; Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016; Chapter 11, Paclitaxel market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021; Chapter 12 and 13, to describe Paclitaxel sales channel, distributors, traders, dealers, appendix and data source.